Cargo Therapeutics Inc

NAS:CRGX (USA)  
$ 18.68 +0.4 (+2.19%) 10:08 PM EST
At Loss
P/B:
1.90
Market Cap:
$ 735.41M
Enterprise V:
$ 342.37M
Volume:
88.80K
Avg Vol (2M):
372.63K
Volume:
88.80K
At Loss
Avg Vol (2M):
372.63K

Business Description

Cargo Therapeutics Inc
NAICS : 541714 SIC : 8731
ISIN : US14179K1016
Compare
Compare
Traded in other countries / regions
CRGX.USA
IPO Date
2023-11-10
Description
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
Name Current Vs Industry Vs History
Cash-To-Debt 14.22
Equity-to-Asset 0.9
Debt-to-Equity 0.07
Debt-to-EBITDA -0.44
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
Future 3-5Y EPS without NRI Growth Rate -13

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 32.11
9-Day RSI 29.68
14-Day RSI 33.88

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 19.35
Quick Ratio 19.35
Cash Ratio 19.17

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % 1.72
Name Current Vs Industry Vs History
ROE % -145.39
ROA % -44.57
ROIC % -151.04
ROC (Joel Greenblatt) % -412.92
ROCE % -57.29

Financials (Next Earnings Date:2024-05-31 Est.)

CRGX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CRGX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Cargo Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.695
Beta 0
Volatility % 0
14-Day RSI 33.88
14-Day ATR ($) 1.450651
20-Day SMA ($) 20.1655
12-1 Month Momentum % 0
52-Week Range ($) 13.14 - 33.92
Shares Outstanding (Mil) 39.37

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cargo Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Cargo Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Cargo Therapeutics Inc Frequently Asked Questions

What is Cargo Therapeutics Inc(CRGX)'s stock price today?
The current price of CRGX is $18.68. The 52 week high of CRGX is $33.92 and 52 week low is $13.14.
When is next earnings date of Cargo Therapeutics Inc(CRGX)?
The next earnings date of Cargo Therapeutics Inc(CRGX) is 2024-05-31 Est..
Does Cargo Therapeutics Inc(CRGX) pay dividends? If so, how much?
Cargo Therapeutics Inc(CRGX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1